# Trial to Evaluate the Efficacy of a Zinc, Selenium, and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191G/A SEPP1 Polymorphism

> **NCT06264544** · NA · NOT_YET_RECRUITING · sponsor: **S.LAB (SOLOWAYS)** · enrollment: 150 (estimated)

## Conditions studied

- Thyrotoxicosis

## Interventions

- **DIETARY_SUPPLEMENT:** zinc, selenium, and L-tyrosine in SEPP1
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06264544
- **Lead sponsor:** S.LAB (SOLOWAYS)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-30
- **Primary completion:** 2025-10-15
- **Final completion:** 2025-12-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06264544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06264544, "Trial to Evaluate the Efficacy of a Zinc, Selenium, and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191G/A SEPP1 Polymorphism". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06264544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*